Results 81 to 90 of about 21,823 (309)

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions

Alimentary Pharmacology &Therapeutics, EarlyView.
Rates of inpatient mortality and complication rates in cirrhosis remain high. With regard to inpatient outcomes, cirrhosis is falling behind other chronic health conditions. ABSTRACT Background The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years.
Julian Pohl, Nirbaanjot Walia, Lukas Hofmann, Lena Wolters, Martin Schulz, Matthias Reinhardt, Brigitta Globke, Frank Tacke, Thomas Berg, Cornelius Engelmann   +9 more
wiley   +1 more source

Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension [PDF]

, 2020
Background and Aims: Transjugular intrahepatic portosystemic shunt (TIPS) is used for decompressing clinically significant portal hypertension. The aims of this study were to evaluate clinical outcomes and adverse events associated with this procedure ...
Bilhim, Tiago, Calinas, Filipe, Coimbra, Élia, Dantas, Eduardo, Martins, Américo, Santos, Sara, Veloso Gomes, Filipe   +6 more
core   +1 more source

Systematic review with meta‐analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis

Alimentary Pharmacology and Therapeutics, 2018
Transjugular intrahepatic portosystemic shunt has been increasingly used in patients with portal vein thrombosis to obtain patency, but evidenced‐based decisions are challenging.
S. Rodrigues, S. Sixt, J. Abraldes, A. de Gottardi, C. Klinger, J. Bosch, I. Baumgartner, A. Berzigotti   +7 more
semanticscholar   +1 more source

Trans-splenic Approach for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation in Patients with Portal Vein Thrombosis

The Arab Journal of Interventional Radiology
Purpose The aim of this study was to evaluate the safety and efficacy of using a trans-splenic approach for transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with portal vein thrombosis. (PVT).
Maryam Boumezrag, George Lynskey, Saher Sabri   +2 more
doaj   +1 more source

A new and improved transjugular intrahepatic portosystemic shunt (TIPS) stent graft: Controlled expansion

Gastrointestinal Intervention, 2018
Initial underdilation of transjugular intrahepatic portosystemic shunt (TIPS) stents has been a widely proposed and commonly practiced technique to balance portal hypertension relief and the adverse effects associated with excess shunting, especially ...
Harry Trieu, Edward Wolfgang Lee
doaj   +1 more source

FIGO guideline on liver disease and pregnancy

International Journal of Gynecology &Obstetrics, Volume 170, Issue 1, Page 28-48, July 2025.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana, Virna Medina, Cynthia Maxwell, Ciara McCormick, Gloria Taliani, Ulrich Beuers, Deborah Money, Bo Jacobsson, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Graeme Smith, Lina Bergman, Sharleen O'Reilly, Patrick O'Brien, Mark Hanson, Mary Rosser, Claudio Sosa, Sumaiya Adam, Valerie Guinto, Liona Poon, Fionnuala McAuliffe, Catherine Williamson, on behalf of the FIGO Committee on Impact of Pregnancy on Long‐term Health, FIGO Committee on Infections during Pregnancy and the FIGO Division of Maternal and Newborn Health   +24 more
wiley   +1 more source

Lipopolysaccharide and toll-like receptor 4 in dogs with congenital portosystemic shunts [PDF]

, 2015
Surgical attenuation of a congenital portosystemic shunt (CPSS) results in increased portal vein perfusion, liver growth and clinical improvement. Portal lipopolysaccharide (LPS) is implicated in liver regeneration via toll-like receptor (TLR) 4 mediated
House, A K, Lipscomb, V J, Smith, K C, Tivers, M S, Wheeler-Jones, C P D   +4 more
core   +2 more sources

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy

World Journal of Gastroenterology, 2019
BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) is currently used for the treatment of complications of portal hypertension. The incidence of hepatic encephalopathy (HE) remains a problem in TIPS placement.
Shihua Luo, J. Chu, He Huang, Guorui Zhao, Kechun Yao   +4 more
semanticscholar   +1 more source

Rifaximin‐α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization

United European Gastroenterology Journal, Volume 13, Issue 6, Page 938-945, July 2025.
ABSTRACT Background and Aims Hepatic encephalopathy is a frequent complication of cirrhosis. Rifaximin‐α has been included in guidelines for secondary prevention of hepatic encephalopathy, but there are few real‐world data on its efficacy and impact on healthcare utilization.
Diederick J. van Doorn, Kirsi. M. A. van Eekhout, Koos de Wit, L. C. Baak, Michael Klemt‐Kropp, Bart J. Verwer, Philip Friederich, Gijs J. de Bruin, Xander G. Vos, Joost P. H. Drenth, R. Bart Takkenberg   +10 more
wiley   +1 more source

Left Ventricular Longitudinal Contractility Predicts Acute‐on‐Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt

Hepatology Communications, 2019
Acute deterioration of liver cirrhosis (e.g., infections, acute‐on‐chronic liver failure [ACLF]) requires an increase in cardiac contractility. The insufficiency to respond to these situations could be deleterious.
C. Jansen, Anna I Schröder, R. Schueler, J. Lehmann, M. Praktiknjo, F. Uschner, R. Schierwagen, Daniel K. Thomas, Sofia Monteiro, G. Nickenig, C. Strassburg, C. Meyer, V. Arroyo, C. Hammerstingl, J. Trebicka   +14 more
semanticscholar   +1 more source